Why we should care about standards of care?

“Standard of care” (SOC) is a legalistic term. As it applies to medicine, wh en a clinician follows an SOC, it means that he or she has proceeded with the reasonable caution that any minimally competent doctor would and should exercise in such circumstances. … READ MORE …

Assessing the “value” of treatment with specific drugs (here in the USA)

Last Friday, the National Comprehensive Cancer Cancer Network (NCCN) introduced a new way for doctors and patients to be able to consider the clinical “value” of treatment with specific drugs in specific forms of cancer. How useful this method is will take a while to work out. … READ MORE …

Guidelines and the current treatment of mCRPC

The December 1 issue of The ASCO Post contains two articles that will be of interest to many patients with progressive disease and their family members. … READ MORE …

ASCO endorses guideline on adjuvant, salvage radiation therapy — with a caution

On Tuesday, the American Society of Clinical Oncology (ASCO) gave its backing to a recent guideline on the use of adjuvant and salvage radiotherapy after radical prostatectomy. The ASCO endorsement (by Freedland et al.) appears in the Journal of Clinical Oncology. It is also discussed on the web site ofThe ASCO Post. … READ MORE …

A guide to PSA screening guidelines

For those who would like to have access to a sound summary of the recommendations of groups around the world on screening for prostate cancer, we can recommend a recent, relatively brief, and straightforward review article recently published in BJU International. … READ MORE …

ASCO, CCO issue new guidelines for management of metastatic prostate cancer

The American Society for Clinical Oncology (ASCO), in conjunction with Cancer Care Ontario (CCO), has just issued revised guidelines for the management of metastatic prostate cancer. … READ MORE …

ACS issues new prostate cancer survivorship care guidelines

As long-time readers of this column will be aware, The “New” Prostate Cancer InfoLink has been less than enthused by some of the attitudes of the American Cancer Society (ACS) when it comes to education of physicians and patients about prostate cancer. However, praise is important when praise is due! … READ MORE …